Guidelines for clinical evaluation of chronic kidney disease : AMED research on regulatory science of pharmaceuticals and medical devices

Affiliations

• ¹ Medical Science, Kawasaki Medical School, Okayama, Japan.
• ² Department of Nephrology and Hypertension, Kawasaki Medical School, Okayama, Japan.
• ³ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Maryland, USA.
• ⁴ Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
• ⁵ Department of Nephrology, Saitama Medical University, Saitama, Japan.
• ⁶ Clinical Research Support Center, Tomishiro Central Hospital, Okinawa, Japan.
• ⁷ Office of New Drug I, Pharmaceuticals and Medical Devices Agency (PMDA), Tokyo, Japan.
• ⁸ Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
• ⁹ Department of Nephrology and Laboratory Medicine, Kanazawa University, Ishikawa, Japan.
• ¹⁰ Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
• ¹¹ Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan.
• ¹² Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. mnangaku-tky@umin.ac.jp.